Mondrian Investment Partners LTD Laboratory Corp Of America Holdings Transaction History

Mondrian Investment Partners LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$209.01 - $232.56 $1.15 Million - $1.28 Million	5,510 Added 0.94%	591,056 $129 Million
Q4 2023 Feb 13, 2024	BUY	$197.69 - $227.29 $1.61 Million - $1.85 Million	8,137 Added 1.41%	585,546 $133 Million
Q3 2023 Nov 06, 2023	SELL	$201.05 - $221.7 $15.7 Million - $17.3 Million	-78,052 Reduced 11.91%	577,409 $116 Million
Q2 2023 Sep 20, 2023	BUY	$211.93 - $241.33 $7.76 Million - $8.84 Million	36,635 Added 5.92%	655,461 $158 Million
Q1 2023 Sep 20, 2023	SELL	$213.32 - $257.83 $7.81 Million - $9.45 Million	-36,635 Reduced 5.59%	618,826 $142 Million
Q1 2023 May 09, 2023	BUY	$213.32 - $257.83 $19 Million - $22.9 Million	88,937 Added 16.78%	618,826 $142 Million
Q4 2022 Feb 03, 2023	BUY	$203.72 - $248.97 $165,013 - $201,665	810 Added 0.15%	529,889 $125 Million
Q3 2022 Oct 21, 2022	BUY	$204.81 - $262.19 $13.2 Million - $16.9 Million	64,436 Added 13.87%	529,079 $108 Million
Q2 2022 Aug 09, 2022	BUY	$213.86 - $277.87 $99.4 Million - $129 Million	464,643 New	464,643 $109 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Mondrian Investment Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Mondrian Investment Partners LTD with notifications on news.